González GYJ, García RI, García FWO

Language: Spanish
References: 32
Page: 81-85
PDF size: 192.03 Kb.

ABSTRACT

Serological examinations have become essential tools in the diagnosis and management of infection with the hepatitis c virus (HCV). These tests include detection of antibodies to HCV in serum, detection and quantification of HCV-RNA, as well as determination of the genotype of HCV in serum. These tests are essential in the diagnosis and therapeutic management of hepatitis c. In this article we make an exhaustive review of the subject.

REFERENCES

1. Strader, D.B., Wright, T., Thomas, D.L. y Seeff, L.B., “Diagnosis, management and treatment of hepatitis c”, Hepatology, 2004, 39 (4): 1147-1171.

2. Komurian-Pradel, F., Paranhos-Baccala, G. et al., “Quantitation of hcv arn using real-time pcr and fluorimetry”, J Virol Methods, 2001, 95 (1-2): 111-119.

3. Halfon, P., Bourliere, M. et al., “Real-time pcr assays for hcv arn quantitation are adecuate for clinical management of patients with chronic hcv infection”, J Clin Microbiology, 2006, 44 (7): 2507-2511.

4. Pawlotsky, J.M., “Molecular diagnosis of viral hepatitis”, Gastroenterology, 2003, 122: 1554-1568.

5. Carey, W., “Tests and screening strategies for the diagnosis for hepatitis c”, Cleveland Clin J Medicine, 2003, 70 (4): 7-13.

6. Pawlotsky, J.M., “Use and interpretation of virological tests for hepatitis c”, Hepatology, 2002, 36 (5): s65-s73.

7. Sun, Z.H., Ma, W. y Zheng, W., “Microarrays development in the diagnosis of hbv and hcv”, Med J Chin pla, 2003, 28: 375-376.

8. Bukh, J., Miller, R.H. y Purcell, R.H., “Genetic heterogeneity of hepatitis c virus: quasispecies and genotypes”, Semin Liver Dis, 1995, 1 (15): 41-63.

9. Zein, N.N., “Clinical significance of hepatitis c virus genotypes”, Clin Microbiol Rev, 2000, 13: 223-225.

10. Lau, J.Y., Davis, G.L., Prescott, L.E., Maertens, G., Lindsay, K.L., Qian, K., Mizokami, M. et al., “Distribution of hepatitis c virus genotypes determined by line probe assay in patients with chronic hepatitis c seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group”, Ann Intern Med, 1996, 124: 868-876.

11. Nousbaum, J.B., Pol, S., Nalpas, N., Landais, P., Berthelot, P., Brechot, C. y Collaborative Study Group, “Hepatitis c virus type 1b (ii) infection in France and Italy”, Ann Intern Med, 1995, 122: 161-168.

12. Michinori, K., “Hepatitis c virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics”, J Infectious Dis, 1995, 172 (4): 934-938.

13. Qu, D., Li, J.S., Vitvitski, L., Mechai, S., Berby, F., Tong, S.P., Bailly, F. et al., “Hepatitis c virus genotypes in France: comparison of clinical features of patients infected with hcv type i and type ii”, J Hepatol, 1994, 21: 70-75.

14. Davis, G., “Monitoring of viral levels during therapy of hepatitis c”, Hepatology, 2002, 36 (5): s145-s151.

15. Simmonds, P., “Viral heterogeneity of the hepatitis c virus”, J Hepatol, 1999, 31 (1): 54-60.

16. Zein, N.N., “Clinical significance of hepatitis c virus genotypes”, Clin Microbiol Rev, 2000, 13: 223-225.

17. Li, J.S., Vitvitski, L., Tong, S.P. y Trepo, C., “Identification of the third major genotype of hepatitis c virus in France”, Biochem Biophys Res Commun, 1994, 199: 1474-1481.

18. Okamoto, H., Sugiyama, Y., Okada, S., Kurai, K., Akahane, Y., Sugai, Y. et al., “Typing hepatitis c virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources”, J Gen Virol, 1992, 73: 673-679.

19. Widell, A., Shev, S., Mansson, S., Zhang, Y.Y., Foberg, U., Norkrans, G. et al., “Genotyping of hepatitis c virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications”, J Med Virol, 1994, 44: 272-279.

20. McOmish, F., Chan, S.W., Dow, B.C., Gillon, J., Frame, W.D., Crawford, R.J., Yap, P.L. et al., “Detection of three types of hepatitis c virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities”, Transfusion, 1993, 33: 7-13.

21. Nakao, T., Enomoto, N., Takada, N., Takada, A. y Date, T., “Typing of hcv genomes by restriction fragment length polymorphism”, J Gen Virol, 1991, 72: 2105-2112.

22. Stuyver, L., Wyseur, A., Van Arnhem, W., Lunel, F., Laurent- Puig, P., Pawlotsky, J.M., Kleter, B. et al., “Hepatitis c virus genotyping by means of 5’-ur/core line probes assays and molecular analysis of untypeable samples”, Virus Res, 1995; 38: 137-157.

23. Stuyver, L., Wyseur, A., Van Arnhem, W., Hernández, F. y Maertens, G., “Second-generation line probe assay for hepatitis c virus genotyping”, J Clin Microbiol, 1996, 34: 2259-2266.

24. Ansaldi, F., Torre, F., Bruzzone, B.M., Picciotto, A., Crovari, P. e Icardi, G., “Evaluation of a new hepatitis c virus sequencing assay as a routine method for genotyping”, J Med Virol, 2001, 63: 17-21.

25. Maertens, G. y Stuyver, L., “Genotypes and genetic variation of hepatitis c virus. The molecular medicine of viral hepatitis”, en T.J. Harrison y A.J. Zuckerman (eds.), Chichester, Gran Bretana, John Wiley & Sons, 1997, pp. 182-233.

26. “Manual de instrucciones del estuche Linear Array Hepatitis c Virus Genotyping Test”, Roche Molecular Systems, 2005.

27. Tsukiyama-Kohara, K., Yamaguchi, K., Maki, N., Ohta, Y., Miki, K., Mizokami, M., Ohba, K.I. et al., “Antigenicity of group i and ii hepatitis c virus polypeptides-molecular basis of diagnosis”, Virology, 1993, 192: 430-437.

28. Dixit, V., Quan, S., Martin, P., Larson, D., Brezina, M., DiNello, R., Sra, K. et al., “Evaluation of a novel genotyping system for hepatitis c virus: strong correlation with standard genotyping methodologies”, J Clin Microbiol, 1995, 33: 2978-2983.

29. Kobayashi, M., Chayana, K., Arase, Y., Tsubota, A., Saitoh, S., Suzuki, Y., Ikeda, K. et al., “Enzyme-linked immunosorbent assay to detect hepatitis c virus serological groups 1 to 6”, J Gastroenterol, 1999, 34: 505-509.

30. Leruez-Ville, M., Nguyen, Q.T., Cohen, P., Cocco, S., Nouyou, M., Ferriere, F. y Deny, P., “Large-scale analysis of hepatitis c virus serological typing assay: effectiveness and limits”, J Med Virol, 1998, 55: 18-23.

31. Gish, R.G., Qian, K.P., Quan, S., Xu, Y.L., Pike, I., Polito, A., Di-Nello, R. et al., “Concordance between hepatitis c virus serotyping assays. J Viral Hepatol 1997; 4: 421-422.

32. Lefrere, J.J., Guiramand, S., Lefrere, F.F., Mariotti, M., Aumont, P., Lerable, J., Petit, J.C. et al., “Full or partial seroreversion in patients infected by hepatitis c virus”, J Infect Dis, 1997, 175: 316-322.